📰 Clinical Development News
Page 80 - Clinical Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Development. Real-time updates on events, politics, business and more.
October 3, 2023
Syndax Pharmaceuticals says it is ‘thrilled’ to report positive top line results for its treatment for acute leukemia.
October 3, 2023
Protagonist Therapeutics Reports Granting of Inducement Award
October 2, 2023
– At Week 26, 81% of patients in Phase 3 PaTHway Trial with chronic post-surgical hypoparathyroidism, the most common cause of this disease, achieved independence from conventional therapy while maintaining normocalcemia following treatment with TransCon PTH – Post-surgical patients treated with TransCon PTH self-reported significant improvements in disease-related symptoms, physical functioning, and daily life compared to those on placebo – Results for post-surgical patient...
October 2, 2023
Calliditas Therapeutics says it is optimistic about getting full marketing authorization for a drug to treat primary IgA nephropathy (IgAN) after submitting a request to the European Medicines Agency (EMA).
October 2, 2023
02.10.2023 - – At Week 26, 81% of patients in Phase 3 PaTHway Trial with chronic post-surgical hypoparathyroidism, the most common cause of this disease, achieved independence from conventional therapy while maintaining normocalcemia following treatment with ... Seite 1
October 2, 2023
Katalin Karikó and Drew Weissman will receive the prize for their discoveries on nucleoside modification, which lead to an effective mRNA-based vaccine.
October 2, 2023
James Christensen, Ph.D., and Nancy Whiting, Pharm.D., join Board of DirectorsGeorge Demetri, M.D., to serve as first member of Clinical Advisory BoardSAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a clinical stage, next-generation precision oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver...
October 1, 2023
/PRNewswire/ -- Vial, a global tech-powered Contract Research Organization (CRO), has announced the second installment of their new online series titled "First...
September 29, 2023
Chinese biopharmaceutical company, Hutchmed Limited, has announced today (Friday September 29) that it has taken a step towards bringing a colon and rectum cancer drug to a third market.